Search Results - "Rogatsch, H"

Refine Results
  1. 1

    Testicular cavernous hemangioma associated with testicular torsion – case report and review of literature by Tepeneu, N.F., Krafka, K., Meglic, S., Rogatsch, H., Fasching, G.

    “…•Testicular hemangioma is exceedingly rare and typically occurs in patients younger than 20 years.•Hemangiomas of the testis have a similar sonographic and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer by Brunner, A, Mayerl, C, Tzankov, A, Verdorfer, I, Tschörner, I, Rogatsch, H, Mikuz, G

    Published in Journal of clinical pathology (01-09-2004)
    “…Aims: Tenascin-C (Tn-C) is an extracellular matrix glycoprotein that is upregulated in malignant tumours. Tn-C promotes cell growth, cell migration, and…”
    Get full text
    Journal Article
  4. 4

    Prostate cancer screening in the Tyrol, Austria: experience and results by Horninger, W, Reissigl, A, Rogatsch, H, Volgger, H, Studen, M, Klocker, H, Bartsch, G

    Published in European journal of cancer (1990) (01-06-2000)
    “…This article summarises the experience and results of different prostate carcinoma screening projects using total prostate specific antigen (PSA) and per cent…”
    Get full text
    Journal Article
  5. 5

    Successful Management of Recurrent Epstein-Barr Virus-Associated Multilocular Leiomyosarcoma After Cardiac Transplantation by Bonatti, H., Hoefer, D., Rogatsch, H., Margreiter, R., Larcher, C., Antretter, H.

    Published in Transplantation proceedings (01-05-2005)
    “…In contrast to Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disorders (PTLD), EBV-associated leiomyomatous tumors have thus far only…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Characteristics of prostate cancers detected at low PSA levels by Horninger, Wolfgang, Berger, A.P., Rogatsch, H., Gschwendtner, A., Steiner, H., Niescher, M., Klocker, H., Bartsch, G.

    Published in The Prostate (15-02-2004)
    “…BACKGROUND When age‐referenced PSA levels as recommended by Oesterling et al.1 were used as a biopsy criterion, only 25% of the cancers detected in a…”
    Get full text
    Journal Article
  7. 7

    Sertoli-Leydig cell tumours of the ovary and testis : a CGH and FISH study by VERDORFER, I, HORST, D, HÖLLRIGL, A, ROGATSCH, H, MIKUZ, G

    “…We present two malignant cases of Sertoli-Leydig cell tumours (SLCT) of the testis and one ovarian SLCT with benign behaviour. The DNA copy number changes…”
    Get full text
    Journal Article
  8. 8

    Molecular-cytogenetic characterisation of sex cord-stromal tumours : CGH analysis in sertoli cell tumours of the testis by VERDORFER, I, HÖLLRIGL, A, STRASSER, U, SUSANI, M, HARTMANN, A, ROGATSCH, H, MIKUZ, G

    “…Sertoli cell tumours (SCT) are rare and poorly explored neoplasias, and the genetic features of these uncommon tumours are largely unknown. Data about…”
    Get full text
    Journal Article
  9. 9

    Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels by Höltl, L, Peschel, R, Knapp, R, Janetschek, G, Steiner, H, Hittmair, A, Rogatsch, H, Bartsch, G, Hobisch, A

    Published in Urology (Ridgewood, N.J.) (2002)
    “…Objectives. To analyze whether primary metastatic spread occurs behind the lumbar vessels and whether removal is necessary for accurate staging in diagnostic…”
    Get full text
    Journal Article
  10. 10

    Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer by Strohmeyer, D, Frauscher, F, Klauser, A, Recheis, W, Eibl, G, Horninger, W, Steiner, H, Volgger, H, Bartsch, G

    Published in Anticancer research (01-07-2001)
    “…The clinical relevance of tumor angiogenesis has been investigated in several human tumors, including prostate carcinoma (PC). Previously, we found…”
    Get more information
    Journal Article
  11. 11

    Leydig cell tumors of the testis : A molecular-cytogenetic study based on a large series of patients by VERDORFER, I, HORST, D, HOLLRIGL, A, SUSANI, M, HARTMANN, A, ROGATSCH, H, MIKUZ, G

    Published in Oncology reports (01-03-2007)
    “…The genetic features of the uncommon Leydig cell tumors (LCT) are largely unknown. Consequently, it is of great importance to elucidate the pathogenesis of…”
    Get full text
    Journal Article
  12. 12

    CD30 expression in seminoma by Hittmair, A, Rogatsch, H, Hobisch, A, Mikuz, G, Feichtinger, H

    Published in Human pathology (01-11-1996)
    “…In testicular germ cell tumors the CD30 antigen has been shown to be regularly expressed in embryonal carcinoma and was thus suggested as a marker for this…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels by Horninger, W., Reissigl, A., Klocker, H., Rogatsch, H., Fink, K., Strasser, H., Bartsch, G.

    Published in The Prostate (01-11-1998)
    “…BACKGROUND The clinical value of prostate‐specific antigen (PSA) density in differentiating between prostate cancer and benign prostatic hyperplasia has been…”
    Get full text
    Journal Article
  15. 15

    MICROVESSEL DENSITY IN CORE BIOPSIES OF PROSTATIC ADENOCARCINOMA: A STAGE PREDICTOR? by ROGATSCH, H., HITTMAIR, A., REISSIGL, A., MIKUZ, G., FEICHTINGER, H.

    Published in The Journal of pathology (01-06-1997)
    “…Microvessel density was recently reported to be an independent correlate of tumour stage in whole mount prostatectomy specimens. This prompted an investigation…”
    Get full text
    Journal Article
  16. 16

    Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project by Horninger, W, Volgger, H, Rogatsch, H, Strohmeyer, D, Steiner, H, Hobisch, A, Klocker, H, Bartsch, G

    Published in The Journal of urology (01-04-2001)
    “…We evaluate the predictive values of total and percent free prostate specific antigen (PSA) in regard to high grade intraepithelial lesions in volunteers who…”
    Get more information
    Journal Article
  17. 17

    Laryngeal intraepithelial neoplasia by Eckel, H E, Raunik, W, Rogatsch, H

    Published in Laryngo- rhino- otologie (01-06-2008)
    “…Precancer (carcinoma in situ) or laryngeal intraepithelial neoplasia (LIN) is a non-invasive lesion that has genetic abnormalities, loss of cellular control…”
    Get more information
    Journal Article
  18. 18

    Expression of vimentin, cytokeratin, and desmin in Sertoli cells of human fetal, cryptorchid, and tumour-adjacent testicular tissue by ROGATSCH, H, JEZEK, D, HITTMAIR, A, MIKUZ, G, FEICHTINGER, H

    “…The intermediate filament of mature human Sertoli cells is vimentin. A co-expression of vimentin together with cytokeratin has been demonstrated in Sertoli…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Prostate cancer screening in Tyrol, Austria: experience and results by Horninger, W, Reissigl, A, Rogatsch, H, Volgger, H, Studen, M, Klocker, H, Bartsch, G

    Published in European urology (1999)
    “…This article summarizes the experience and results of different prostate carcinoma screening projects using total prostate-specific antigen (PSA) and percent…”
    Get more information
    Journal Article